Issues related to drug pricing Issues related to clinical trial reform Issues related to vaccine policy
2026 · 3rd Quarter (July 1 - Sep 30)
PFIZER INC.
Filed by THE DUBERSTEIN GROUP INC..
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- THE DUBERSTEIN GROUP INC.
- Client
- PFIZER INC.
- Filing UUID
- 82556404-db47-4de2-93c3-92df5fe69db2
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to MFN pricing and trade
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.